Technology venture capital company MTI Partners has completed an investment round of GBP1.19m in Eykona, an Oxford University spin-out medical technology company.
The round, which was over-subscribed, allows Eykona to progress its 3D wound imaging system to launch and beyond.
The financing was led by MTI through the UMIP Premier Fund alongside further investment from existing and new shareholders including H2O Venture Partners, Parkwalk EIS Technology Fund 1, Hygea VCT, the LBA Roundtable EIS Fund 2009 with three LBA investors and a number of other Angel investors.
Technikos remains the largest shareholder.
Paul Murphy, chief executive of Eykona, says: “We are at an exciting stage with Eykona; we have great clinical support, a strong health economic rationale and huge interest from the wound care community. Allowing clinicians to measure wounds, accurately and repeatably, will help improve outcomes, reduce costs and ensure that patients with serious wounds are treated optimally.”
David Holbrook, partner and head of medtech investing at MTI, adds: “This is cutting edge technology addressing a key unmet need in the wound care marketplace, with strong clinician endorsement and management team. These are the perfect building blocks for success. We are delighted to have led this round.”
